Stimuli-Responsive Covalent Organic Frameworks for Cancer Therapy
Masoud Nejabat1, Ali Samie2,3, Amir Khojastehnezhad4
1Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad 91388-13944, Iran.
ACS Applied Materials & Interfaces
|August 20, 2024
Summary
Stimuli-responsive covalent organic framework (COF) nanostructures offer advanced cancer treatment by overcoming chemotherapy limitations. These COFs enable precise drug delivery and combination therapies for enhanced anticancer efficacy.
Area of Science:
- Biomedical Engineering
- Materials Science
- Oncology
Background:
- Chemotherapy faces challenges including poor drug stability, low solubility, severe side effects, and multidrug resistance.
- Nanoparticles offer solutions as drug carriers and platforms for combined therapeutic approaches.
- Stimuli-responsive nanoparticles, triggered by tumor microenvironment or external stimuli, enhance treatment precision and selectivity.
Purpose of the Study:
- To review the potential of stimuli-responsive nanoscale covalent organic frameworks (COFs) in cancer treatment.
- To explore COFs for chemotherapy alone and in combination with other therapies.
- To highlight COFs' role in overcoming traditional chemotherapy drawbacks.
Main Methods:
- Review of recent literature on covalent organic frameworks (COFs) in nanomedicine.
- Focus on stimuli-responsive characteristics of COF nanostructures.
- Analysis of COFs' application in chemotherapy, sonodynamic, chemodynamic, photodynamic, and photothermal therapies.
Main Results:
- Covalent organic frameworks (COFs) exhibit desirable properties like large surface area, high porosity, structural stability, and biocompatibility.
- Nanoscale COFs show promise as platforms for drug delivery and combination cancer therapies.
- Stimuli-responsive COFs can be designed to target specific tumor microenvironment characteristics or respond to external triggers.
Conclusions:
- Nanoscale covalent organic frameworks (COFs) represent a promising strategy for advanced cancer therapy.
- Their stimuli-responsive nature allows for targeted drug delivery and enhanced combination treatments.
- COFs have significant potential to improve efficacy and reduce side effects compared to conventional chemotherapy.
Related Concept Videos
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
Tumor Immunotherapy
493
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
493


